Terug
Dagbereik
€ 243,18
€ 252,83
52-Weeksbereik
€ 122,80
€ 298,30
Volume
271.518
50D / 200D Gem.
€ 269,80
/
€ 199,95
Vorige Slotkoers
€ 250,08
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 35,3 | 0,3 |
| P/B | 5,9 | 2,9 |
| ROE % | 18,9 | 3,7 |
| Net Margin % | 52,6 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 311,00
+25.9%
Low: € 224,00
High: € 371,00
Forward K/W
32,5
Forward WPA
€ 7,70
WPA Groei (sch.)
+0,0%
Omzet Sch.
530 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 27,11
€ 20,97 – € 34,60
|
1,5 B | 1 |
| FY2029 |
€ 20,30
€ 15,70 – € 25,90
|
1,1 B | 1 |
| FY2028 |
€ 13,46
€ 8,34 – € 27,13
|
900 M | 5 |
Belangrijkste Punten
Earnings grew 129,74% over the past year
ROE of 18,91% — decent returns on equity
Net margin of 52,64% shows strong profitability
Debt/Equity of 0,01 — conservative balance sheet
Generating 188,91M in free cash flow
P/E of 35,26 — premium valuation
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)33,94%
Earnings (1Y)129,74%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
18,91%
ROIC9,84%
Net Margin52,64%
Op. Margin41,45%
Veiligheid
Debt / Equity
0,01
Current Ratio9,95
Interest Coverage0,00
Waardering
P/E Ratio
35,26
P/B Ratio5,92
EV/EBITDA41,76
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 33,94% | Revenue Growth (3Y) | 177,04% |
| Earnings Growth (1Y) | 129,74% | Earnings Growth (3Y) | 332,86% |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 389,13M | Net Income (TTM) | 204,83M |
| ROE | 18,91% | ROA | 15,36% |
| Gross Margin | 92,61% | Operating Margin | 41,45% |
| Net Margin | 52,64% | Free Cash Flow (TTM) | 188,91M |
| ROIC | 9,84% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 9,95 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 35,26 | P/B Ratio | 5,92 |
| P/S Ratio | 18,56 | PEG Ratio | 0,27 |
| EV/EBITDA | 41,76 | Dividend Yield | 0,00% |
| Market Cap | 7,22B | Enterprise Value | 6,74B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 389,13M | 290,52M | 50,70M | 0,0 | 0,0 |
| Net Income | 204,83M | 89,16M | 10,93M | -139,98M | -69,57M |
| EPS (Diluted) | 6,84 | 3,00 | 0,39 | -5,49 | -3,13 |
| Gross Profit | 360,36M | 270,45M | 47,61M | 0,0 | 0,0 |
| Operating Income | 161,30M | 65,70M | -109,73M | -145,20M | -68,28M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,33B | 1,06B | 818,36M | 558,45M | 626,30M |
| Total Liabilities | 114,23M | 109,46M | 39,71M | 36,22M | 32,72M |
| Shareholders' Equity | 1,22B | 946,38M | 778,64M | 522,23M | 593,58M |
| Total Debt | 9,34M | 7,26M | 8,09M | 8,93M | 8,02M |
| Cash & Equivalents | 496,30M | 344,87M | 358,33M | 161,90M | 341,25M |
| Current Assets | 1,02B | 742,05M | 587,91M | 383,78M | 442,27M |
| Current Liabilities | 102,94M | 102,00M | 33,09M | 28,85M | 25,74M |